Axxcess Wealth Management LLC cut its position in Corteva, Inc. (NYSE:CTVA – Free Report) by 1.4% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 43,634 shares of the company’s stock after selling 641 shares during the period. Axxcess Wealth Management LLC’s holdings in Corteva were worth $2,516,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds and other institutional investors have also modified their holdings of the company. Capital International Investors boosted its holdings in Corteva by 47.2% in the fourth quarter. Capital International Investors now owns 25,758,735 shares of the company’s stock valued at $1,234,359,000 after purchasing an additional 8,260,808 shares in the last quarter. Norges Bank acquired a new position in shares of Corteva in the 4th quarter valued at $265,298,000. Harris Associates L P grew its position in shares of Corteva by 87.1% in the 4th quarter. Harris Associates L P now owns 9,011,702 shares of the company’s stock valued at $431,841,000 after buying an additional 4,194,981 shares during the last quarter. Glenview Capital Management LLC raised its stake in Corteva by 116.6% during the 4th quarter. Glenview Capital Management LLC now owns 4,698,725 shares of the company’s stock worth $225,163,000 after acquiring an additional 2,529,539 shares in the last quarter. Finally, Massachusetts Financial Services Co. MA lifted its position in Corteva by 19.3% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 13,236,504 shares of the company’s stock valued at $634,293,000 after acquiring an additional 2,141,428 shares during the last quarter. 81.54% of the stock is currently owned by institutional investors and hedge funds.
Insider Buying and Selling
In other news, insider Brian Titus sold 12,134 shares of the company’s stock in a transaction dated Monday, May 6th. The shares were sold at an average price of $56.65, for a total transaction of $687,391.10. Following the completion of the transaction, the insider now owns 13,495 shares in the company, valued at $764,491.75. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other Corteva news, insider Brian Titus sold 12,134 shares of Corteva stock in a transaction on Monday, May 6th. The stock was sold at an average price of $56.65, for a total transaction of $687,391.10. Following the sale, the insider now owns 13,495 shares of the company’s stock, valued at approximately $764,491.75. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Cornel B. Fuerer sold 39,736 shares of the business’s stock in a transaction on Tuesday, May 14th. The stock was sold at an average price of $57.41, for a total value of $2,281,243.76. Following the transaction, the senior vice president now owns 126,628 shares of the company’s stock, valued at approximately $7,269,713.48. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 83,556 shares of company stock valued at $4,795,016. Insiders own 0.14% of the company’s stock.
Analyst Ratings Changes
Get Our Latest Stock Analysis on Corteva
Corteva Stock Up 0.2 %
CTVA stock traded up $0.11 during mid-day trading on Friday, hitting $55.39. 2,271,938 shares of the company were exchanged, compared to its average volume of 3,425,468. The firm has a fifty day simple moving average of $53.70 and a 200 day simple moving average of $53.52. The company has a market capitalization of $38.61 billion, a PE ratio of 70.48, a price-to-earnings-growth ratio of 1.45 and a beta of 0.77. Corteva, Inc. has a twelve month low of $43.22 and a twelve month high of $58.76. The company has a current ratio of 1.51, a quick ratio of 0.97 and a debt-to-equity ratio of 0.10.
Corteva (NYSE:CTVA – Get Free Report) last released its earnings results on Wednesday, May 1st. The company reported $0.89 EPS for the quarter, topping analysts’ consensus estimates of $0.79 by $0.10. Corteva had a return on equity of 6.68% and a net margin of 3.32%. The company had revenue of $4.49 billion for the quarter, compared to the consensus estimate of $4.65 billion. During the same quarter last year, the business posted $1.16 EPS. Corteva’s quarterly revenue was down 8.0% compared to the same quarter last year. On average, research analysts forecast that Corteva, Inc. will post 2.78 earnings per share for the current fiscal year.
Corteva Company Profile
Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.
Read More
- Five stocks we like better than Corteva
- Why Invest in High-Yield Dividend Stocks?
- 3M Surprises and Rebound Accelerates: It Isn’t Too Late To Get In
- How Can Investors Benefit From After-Hours Trading
- Skechers Stock Shows Strength Among Consumer Discretionary Sector
- What Are Dividend Champions? How to Invest in the Champions
- Tech Stocks Tumble, These Stocks Present Buying Opportunity
Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA – Free Report).
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.